Morningstar, Inc. (NASDAQ: MORN) Executive Chairman Joseph D. Mansueto has trimmed his stake in the financial services firm, selling 7,250 shares of common stock on November 16, 2026, according to a regulatory filing. The transaction was valued at approximately $1.8 million, with individual sale prices spanning from $246.8944 to $249.9062 per share.
The sale was conducted pursuant to a Rule 10b5-1 trading plan that Mansueto adopted on June 8, 2026. Such plans allow company insiders to set up predetermined schedules for buying or selling shares, providing a defense against allegations of trading on material nonpublic information.
The disposal comes as Morningstar's stock trades close to its 52-week high of $251.04. Shares have rallied 39% over the past six months, a performance that has drawn attention to the company's valuation. According to an analysis referenced in the filing, the stock appears undervalued at current levels, even after the strong run. Morningstar's market capitalization stands at $8.82 billion.
Following the transactions, Mansueto directly holds 8,550,794 shares of Morningstar common stock. In addition, he indirectly beneficially owns 5,600,034 shares through grantor retained annuity trusts, where he serves as trustee for his benefit and that of his children. A further 150,000 shares are held indirectly in trusts for the benefit of his children, with his spouse acting as trustee.
The sale represents a small fraction of Mansueto's overall holdings, which include both direct and indirect positions. Insider transactions are closely monitored by investors for signals about management's confidence in the company's prospects. However, sales made under pre-arranged 10b5-1 plans are often scheduled in advance and may not reflect a change in an executive's view of the business.
Morningstar, known for its investment research and data services, has seen its shares climb steadily over the past six months. The stock's advance has outpaced the broader market, though the filing does not provide comparative index performance. The company's market value of $8.82 billion places it among the larger players in the financial data and analytics space.
Investors will continue to watch insider activity for further clues about the company's trajectory. The filing did not disclose any additional details about Mansueto's plans for his remaining holdings.